|
Pharmaceutical Technology's Annual Employment Survey
|
|
|
| By
Maribel Rios
|
|
|
|
Nearly 1300 pharmaceutical employees provide insights into the issues most relevant to their jobs and the state of the industry workforce today.
|
|
|
|
30 Years Hence: It Won't Be Your Parents' Pharmaceutical Industry
|
|
|
| By
Michelle Hoffman
|
|
|
|
"May you live in interesting times," goes the allegedly ancient Chinese curse. Well, these have been "interesting times" indeed for those working in the pharmaceutical industry.
|
|
|
|
What's Next in: Strategy and Regulation
|
|
|
| By
Maribel Rios
,
Jill Wechsler
|
|
|
|
There are at least two major factors that will shape the manufacturing industry as a whole. Daniel Ruppar, Industry Manager (North America) for the Pharmaceuticals and Biotechnology Division of Frost & Sullivan predicts that, due to continued globalization, we can expect to see "growth centers for the industry move to emerging market sectors."
|
|
|
|
What's Next In: Outsourcing
|
|
|
| By
Jim Miller
|
|
|
|
Contract service providers exist to help clients meet their strategic and financial business objectives. So any prognostication on what the pharmaceutical outsourcing industry will look like in 30 years is really a forecast of the nature and speed of changes in pharmaceutical technologies and business models.
|
|
|
|
What's Next In: Solid-Dosage Formulation
|
|
|
| By
Robin Bogner
,
Stuart C. Porter
,
Albert W. Brzeczko
|
|
|
|
Individualized dosing for specific patient needs has been the goal of medical and pharmacotherapy specialists since they first envisioned pharmacogenetic evaluation. With the measurement of individual levels of metabolism, the optimum dose can be calculated for each individual patient.
|
|
|
|
What's Next In: Ingredients
|
|
|
| By
Richard L. Pederson, PhD
|
|
|
|
Catalysis plays a critical role in the synthesis of active pharmaceutical ingredients (APIs). It provides a way to improve yield, achieve desired stereoselectivity, improve reaction conditions, and synthesize increasingly complex APIs. Recent advances in catalyzed-olefin metathesis reveal its value and promise in the pharmaceutical industry.
|
|
|
|
What's Next In: Drug Delivery
|
|
|
| By
Mansoor M. Amiji
|
|
|
|
Nanotechnology offers an unprecedented opportunity in the rational delivery of drugs and vaccines (1, 2–4).
|
|
|
|
What's Next In: Packaging
|
|
|
| By
Hallie Forcinio
|
|
|
|
Although the highly regulated pharmaceutical industry tends to be more like the tortoise than the hare when it comes to adopting new ideas, pharmaceutical packaging will be dramatically different 30 years from now in 2037.
|
|
|
|
What's Next In: Analytical Testing
|
|
|
| By
Maribel Rios
|
|
|
|
Industry and regulatory organizations agree that the current focus on product quality will play a major role in shaping pharmaceutical development in the future. Key to this assessment of quality are the methods and technologies in pharmaceutical analytical testing.
|
|
|
|
What's Next In: Information Technology
|
|
|
| By
Herschel Kenney
,
Milind Joshi
|
|
|
|
I foresee dramatic future changes in five distinct areas of the pharmaceutical industry: Research, Regulatory Approval, Production, Sales & Marketing, and IT Infrastructure.
|
|
|
